ESMO 2024 Poster - Results of the Phase 1b Study of NC410 Combined with[...]
ESMO 2024 Poster - Results of the Phase 1b Study of NC410 Combined with[...]
03/12/2025 | Press release | Distributed by Public on 03/12/2025 06:16
Smartlinks | Ovid Therapeutics Inc. | News | Health | Company News | Top Company News | Pharmaceuticals | Securities Issuers | Biotechnology and Medical Research Companies | Frankfurt Stock Exchange | Berlin Stock Exchange | Dusseldorf Stock Exchange | Munich Stock Exchange | Stuttgart Stock Exchange | Tradegate Exchange | NYSE American | NYSE ARCA Equities | Nasdaq Global Select Market | Cboe BZX Exchange | Cboe BYX Exchange | Cboe EDGA Exchange | Cboe EDGX Exchange | NYSE National | FINRA Alternative Display Facility (ADF) | Nasdaq BX | Nasdaq PSX | NYSE Chicago
Copyright ©2006-2025 Public Technologies (PUBT) | Privacy Policy | Terms of Use | Contact